CLINICAL_TRIALS
trial_result
· 2024-03-15
Clinical Trial Update: Dupixent and Narrowband UVB for Atopic Dermatitis [Phase 4]
Summary
Phase 4 clinical trial update examining Dupixent in combination with Narrowband UVB for atopic dermatitis, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING